CytomX Therapeutics CTMX, a clinical-stage oncology company, is slated to report its fourth-quarter 2024 earnings results on ...
Dine Brands Global (NYSE:DIN) is scheduled to announce Q4 earnings results on Wednesday, March 5th, before market open. The consensus EPS Estimate is $1.35 (-3.6% Y/Y) and the consensus Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback